Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $920.00 Price Target at HSBC

Summary by MarketBeat
HSBC boosted their price objective on shares of Regeneron Pharmaceuticals from $800.00 to $920.00 and gave the stock a "buy" rating in a research note on Thursday.

1 Articles

MarketBeatMarketBeat
Center

Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $920.00 Price Target at HSBC

HSBC boosted their price objective on shares of Regeneron Pharmaceuticals from $800.00 to $920.00 and gave the stock a "buy" rating in a research note on Thursday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, September 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets icon

Stock Markets

Tarrytown icon

Tarrytown

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal